|
Cedrik M. Britten, MD
Johannes Gutenberg University
Lisa H. Butterfield, PhD
University of Pittsburgh
Damien Chaussabel, PhD
Baylor Institute for Immunology Research
Mark M. Davis, PhD
Howard Hughes Medical Institute / Stanford University School of Medicine
Madhav Dhodapkar, MD
Yale University
Mary (Nora) Disis, MD
University of Washington
Bernard A. Fox, PhD
Earle A. Chiles Research Institute
James W. Jacobson, PhD
Cancer Diagnosis Program, DCTD, NCI
Sylvia Janetzki, MD
ZellNet Consulting
Samir Khleif, MD
National Cancer Institute
Steven Kozlowski, MD
Food and Drug Administration, Office of Biotechnology Products
Alan L. Landay, PhD
Rush University Medical Center
Peter P. Lee, MD
Stanford University
Lance Liotta, MD, PhD
George Mason University
|
Holden T. Maecker, PhD
Stanford University Medical Center
Vernon C. Maino, PhD
BD Biosciences
Anatoli M. Malyguine, MD, PhD
SAIC-Frederick, Inc., NCI-Frederick
Francesco Marincola, MD
National Institutes of Health
Shawnmarie Mayard-Chung, PhD, JD
National Institutes of Health - Office of the Director, OPSA Public-Private Partnerships Program
A. Karolina Palucka, MD, PhD
Baylor Instiute for Immunology Research
Douglas M. Potter, PhD
University of Pittsburgh
Licia Rivoltini, MD
Fondazione IRCCS Istituto Nazionale dei Tumori
Lupe G. Salazar, MD
University of Washington
Rafick-Pierre Sékaly, PhD
University of Montreal; VGTI Florida
David Stroncek, MD
Cell Processing, DTM, CC, National Institutes of Health
Hideaki Tahara, MD, PhD
University of Tokyo
Giorgio Trinchieri, MD
National Cancer Institute
Theresa L. Whiteside, PhD
University of Pittsburgh Cancer Institute
|
